SGRT improves treatment accuracy by using real-time 3D imaging to track patient movements, eliminating the need for tattoo markings. It enhances precision in treating breast and lung cancers while minimising radiation exposure to critical organs
Published Mar 15, 2025 | 10:20 PM ⚊ Updated Mar 16, 2025 | 12:04 PM
Kerala’s Thiruvananthapuram Regional Cancer Center introduces advanced surface guided radiation therapy
Synopsis: The Thiruvananthapuram Regional Cancer Center (RCC) has introduced Surface Guided Radiation Therapy (SGRT), becoming Kerala’s first government facility to implement it. Health Minister Veena George highlighted SGRT’s ability to deliver precise radiation, targeting only cancer cells while protecting healthy tissues. This advanced technology uses real-time 3D imaging, enhancing accuracy in treating breast and lung cancers while reducing radiation exposure to vital organs
In a significant advancement in cancer treatment, the Thiruvananthapuram Regional Cancer Center (RCC) has become the first government facility in Kerala to introduce Surface Guided Radiation Therapy (SGRT). Health Minister Veena George announced that this technology allows for highly precise radiation delivery, targeting only cancer cells while minimizing damage to healthy tissues.
#Kerala : In a major breakthrough in #cancer treatment, the #Thiruvananthapuram Regional Cancer Center (RCC) has introduced Surface Guided Radiation Therapy (SGRT), making it the first government facility in the state to implement this advanced technology.
Health Minister… pic.twitter.com/u9FhXryV1i
— South First (@TheSouthfirst) March 15, 2025
Unlike traditional radiation therapy, which requires tattoo markings on the body, SGRT enhances treatment accuracy by using real-time 3D imaging to track patient movements. This approach ensures better precision, particularly in the treatment of breast and lung cancers, as it reduces radiation exposure to critical organs such as the heart and lungs.
The SGRT technology also synchronises radiation with the patient’s breathing, significantly lowering the risk of long-term side effects.
With the addition of this advanced treatment, RCC reinforces its position as a leading center for cutting-edge cancer care in the government sector.
(Edited by Ananya Rao with inputs from Dileep V Kumar)
